← Back to Search

Prosthetic Knee

Reboocon Intuy Knee for Amputation

N/A
Recruiting
Led By Jennifer Johansson, MS
Research Sponsored by Liberating Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are at least 18 years old
Transfemoral prosthesis user (limb absence between the knee and hip)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start of study (0 months), 3 months, 6 months, 9 months
Awards & highlights

Study Summary

This trial aims to collect data from people with above-the-knee amputations to help doctors choose the best powered prosthetic knee for each patient. The data will be used to guide the prescription of

Who is the study for?
This trial is for individuals with above-knee amputations, specifically K2-level transfemoral amputees. It's aimed at those who use prosthetic knees and are looking to improve their mobility. The study excludes certain groups based on specific criteria not provided here.Check my eligibility
What is being tested?
The study compares non-powered (Reboocon Intuy Knee) versus powered (Ossur Power Knee) prosthetic knees in people with leg amputations. It aims to determine which device offers the most benefit in real-world settings outside of a lab environment.See study design
What are the potential side effects?
While specific side effects are not listed, potential issues may include discomfort, skin irritation, or difficulty adapting to the new prosthesis. More details would be needed for a comprehensive list.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I use a prosthetic leg that fits between my knee and hip.
Select...
My weight is between 110lbs and 256lbs.
Select...
I have used a prosthesis for at least six months.
Select...
I wear a prosthesis for most of the week.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start of study (0 months), 3 months, 6 months, 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and start of study (0 months), 3 months, 6 months, 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Activities-Specific Balance Confidence scale (ABC) - Measuring change from baseline
Prosthesis Evaluation Questionnaire - Well Being (PEQ-WB) - Measuring change from baseline
Step count
Secondary outcome measures
Borg Rating of Perceived Exertion (Borg RPE)
Oswestry Disability Index (ODI)
Patient Reported Outcomes Measures Information System - 29 (PROMIS-29)
+8 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Reboocon Intuy KneeExperimental Treatment1 Intervention
The subject will wear the Reboocon Intuy Knee for 3 months, as well as in the lab to complete outcome measures.
Group II: Ossur Power KneeExperimental Treatment1 Intervention
The subject will wear the Ossur Power Knee for 3 months, as well as in the lab to complete outcome measures.
Group III: Comparator BaselineActive Control1 Intervention
The subject will wear the Ossur OFM-2, a passive mechanical knee which is the most commonly used knee for K2 users, for 3 months, as well as in the lab to complete outcome measures.

Find a Location

Who is running the clinical trial?

Liberating Technologies, Inc.Lead Sponsor
11 Previous Clinical Trials
71 Total Patients Enrolled
Hanger Clinic: Prosthetics & OrthoticsOTHER
9 Previous Clinical Trials
369 Total Patients Enrolled
Jennifer Johansson, MSPrincipal InvestigatorLiberating Technologies, Inc.
1 Previous Clinical Trials
12 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Indeed, according to the information provided on clinicaltrials.gov, this trial is presently seeking eligible participants. The initial posting of the study occurred on September 12th, 2023, and it was most recently updated on December 22nd, 2023."

Answered by AI

What is the current number of individuals enrolled in this medical study?

"Indeed, the information available on clinicaltrials.gov confirms that this study is actively seeking eligible participants. The trial was initially posted on September 12th, 2023 and underwent its most recent update on December 22nd, 2023. A total of 26 patients will be enrolled from a single designated site."

Answered by AI

What are the specific objectives of this research study?

"The primary outcome measure for this clinical trial is the Activities-Specific Balance Confidence scale (ABC), which will be used to assess changes from baseline over the entire 9-month study period. Secondary outcomes include the Stair Assessment Index (SAI), a 14-level ordinal scale that evaluates an individual's ability to ascend and descend stairs, as well as the Timed Up and Go Test (TUG), which measures physical mobility by timing how long it takes for participants to rise from a chair, walk to a marker, turn around, return, and sit back down. Additionally, Patient Reported Outcomes Measures Information System - Physical Function (P"

Answered by AI
~17 spots leftby Aug 2025